These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor. Greene DA; Lattimer SA Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175 [TBL] [Abstract][Full Text] [Related]
24. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. Stevens MJ; Dananberg J; Feldman EL; Lattimer SA; Kamijo M; Thomas TP; Shindo H; Sima AA; Greene DA J Clin Invest; 1994 Aug; 94(2):853-9. PubMed ID: 8040341 [TBL] [Abstract][Full Text] [Related]
25. Studies of resistance to ischemic nerve conduction failure in normal and diabetic rats. Parry GJ; Kohzu H J Neurol Sci; 1989 Oct; 93(1):61-7. PubMed ID: 2681540 [TBL] [Abstract][Full Text] [Related]
26. The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil. Yeh LA; Ashton MA Metabolism; 1990 Jun; 39(6):619-22. PubMed ID: 2112676 [TBL] [Abstract][Full Text] [Related]
27. Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Tomlinson DR; Holmes PR; Mayer JH Neurosci Lett; 1982 Aug; 31(2):189-93. PubMed ID: 6182509 [No Abstract] [Full Text] [Related]
28. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy. Parry GJ; Kozu H Neurology; 1990 Sep; 40(9):1446-9. PubMed ID: 2392233 [TBL] [Abstract][Full Text] [Related]
29. Resistance to ischemic conduction block of the peripheral nerve in hyperglycemic rats: an electrophysiological study. Shirabe S; Kinoshita I; Matsuo H; Takashima H; Nakamura T; Tsujihata M; Nagataki S Muscle Nerve; 1988 Jun; 11(6):582-7. PubMed ID: 3386666 [TBL] [Abstract][Full Text] [Related]
30. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy. Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910 [TBL] [Abstract][Full Text] [Related]
31. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors. Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606 [TBL] [Abstract][Full Text] [Related]
32. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455 [TBL] [Abstract][Full Text] [Related]
33. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition. Greene DA; Mackway AM Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804 [TBL] [Abstract][Full Text] [Related]
34. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats. Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038 [TBL] [Abstract][Full Text] [Related]
35. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats. Funada M; Okamoto I; Fujinaga Y; Yamana T Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085 [TBL] [Abstract][Full Text] [Related]
36. Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat. Kuzumoto Y; Kusunoki S; Kato N; Kihara M; Low PA Diabetologia; 2006 Dec; 49(12):3085-93. PubMed ID: 17063327 [TBL] [Abstract][Full Text] [Related]
37. Effect of streptozotocin diabetes on motor and inhibitory transmission in rat anococcygeus. Luheshi GN; Zar MA Can J Physiol Pharmacol; 1992 Oct; 70(10):1372-8. PubMed ID: 1337014 [TBL] [Abstract][Full Text] [Related]
38. Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Low PA; Ward K; Schmelzer JD; Brimijoin S Am J Physiol; 1985 Apr; 248(4 Pt 1):E457-62. PubMed ID: 3985144 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE; Cotter MA; Basso M; Hohman TC Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964 [TBL] [Abstract][Full Text] [Related]
40. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes]. Kuchmerovskaia TM; Donchenko GV; Klimenko AP; Chichkovskaia GV; Pakirbaeva LV; Kozitskiĭ ZIa; Efimov AS Ukr Biokhim Zh (1978); 1997; 69(3):77-82. PubMed ID: 9505366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]